(Q43591799)

English

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Janssen MJ

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Van Oijen AH

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Verbeek AL

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jansen JB

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

De Boer WA

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

613-624

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Unhealed duodenal ulcers despite Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Meta-analysis: principles and procedures

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Bias in location and selection of studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Antibiotic resistance in Helicobacter pylori: implications for therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Regular review: treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00974.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2001.00974.X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43591799&oldid=2101743123"